Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TapGenes
AddedFeb 17, 2024
UpdatedJun 18, 2026
TapGenes

TapGenes

Seed

TapGenes: A platform for families to manage, share, and act on collective health information.

HQ
Chicago, IL, US
Founded
2013
Overview
Compare
Fundraising
Employees

TapGenes is dedicated to empowering families by providing a platform to manage, share, and act on collective health information. The service focuses on preventive health actions, enabling users to collect and save vital health data. By fostering a collaborative approach to health management, TapGenes aims to enhance family well-being and care.

TapGenes has made significant strides in the health tech industry, helping numerous families take proactive steps in managing their health. The platform's impact is evidenced by its growing user base and positive feedback from families who benefit from its comprehensive health management tools.

TapGenes - Similar Companies

Geno.Me logo

Geno.Me

yourgeno.me

Trellis Health logo

Trellis Health

FamGenix logo

FamGenix

famgenix.com

Unite Genomics logo

Unite Genomics

My Gene Counsel logo

My Gene Counsel

mygenecounsel.com

General Genomics logo

General Genomics

ggenomics.com

Geneial logo

Geneial

geneial.com

CancerIQ logo

CancerIQ

Care2Manage logo

Care2Manage

Genterpret logo

Genterpret

EmbraceFamily Health logo

EmbraceFamily Health

Color logo

Color

color.com

PanGenX logo

PanGenX

Geneticure logo

Geneticure

geneticure.com

Health Global Connect logo

Health Global Connect

TapGenes - Quick Facts

Who are TapGenes' competitors?

Companies similar to TapGenes include Geno.Me, Trellis Health, FamGenix and Unite Genomics.

When was TapGenes founded?

TapGenes was founded in 2013.

Where is TapGenes' headquarters located?

TapGenes' headquarters is located in Chicago, IL, US.

When was TapGenes' last funding round?

TapGenes' most recent funding round was for $20k (USD) in February 2015.

How much has TapGenes raised to-date?

As of Feb 5, 2015, TapGenes has raised a total of $20k (USD).

How many employees does TapGenes have?

TapGenes has 7 employees as of Feb 4, 2024.

TapGenes - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Consumers
Main Product
  • Family Health
  • Health Information
Tags
  • Healthtech
NAICS
  • 621000Ambulatory Health Care Services
  • 621600Home Health Care Services
  • 621610Home Health Care Services
  • 620000Health Care and Social Assistance
SIC
  • 8080Home Health Care Services
  • 8082Home Health Care Services
  • 8000Health Services
Show 2 more industry codes
SIC
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified